Company
Headquarters: Torun, Poland
Employees: 3,681
€941.4 Million
EUR as of July 1, 2024
US$1.01 Billion
Company | Market Cap (USD) |
---|---|
Lilly | $808.65 B |
Novo Nordisk | $622.07 B |
UnitedHealth Group | $450.89 B |
Johnson & Johnson | $350.63 B |
Merck | $318.75 B |
NEUCA S.A. engages in the distribution of pharmaceuticals to pharmacies and hospitals in Poland. It operates through Pharmaceutical Wholesale; Own Brands; and Outpatient Care Clinics, Clinical Trials and Telemedicine segments. It also provides logistic and distribution services, such as national and international transport; lease space for pharmaceutical wholesalers; import and custom; product packaging and repackaging; intervention channel; and tailored services. In addition, it is involved of provision advertising and marketing services; pharmaceutical products under its own brand; and operation of outpatient care clinics, as well as provision of clinical trials and telemedicine. The company was formerly known as Torfarm SA and changed its name to NEUCA S.A. in April 2010. NEUCA S.A. was founded in 1990 and is based in Torun, Poland.
Top 1-year algo backtest: +265.99%
$10,000 in October 2023 would now be $36,599 by following this algorithm daily at market close.
Use AI to boost your investing & swing trading, now!
Try Disfold DeepFinance FREE
NEUCA SA has the following listings and related stock indices.
Stock: FSX: 7HD wb_incandescent